APA
Arabi Y. M., Asiri A. Y., Assiri A. M., Aziz Jokhdar H. A., Alothman A., Balkhy H. H., AlJohani S., Al Harbi S., Kojan S., Al Jeraisy M., Deeb A. M., Memish Z. A., Ghazal S., Al Faraj S., Al-Hameed F., AlSaedi A., Mandourah Y., Al Mekhlafi G. A., Sherbeeni N. M., Elzein F. E., Almotairi A., Al Bshabshe A., Kharaba A., Jose J., Al Harthy A., Al Sulaiman M., Mady A., Fowler R. A., Hayden F. G., Al-Dawood A., Abdelzaher M., Bajhmom W. & Hussein M. A. (20200916). Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial. : Trials.
Chicago
Arabi Yaseen M, Asiri Ayed Y, Assiri Abdullah M, Aziz Jokhdar Hani A, Alothman Adel, Balkhy Hanan H, AlJohani Sameera, Al Harbi Shmeylan, Kojan Suleiman, Al Jeraisy Majed, Deeb Ahmad M, Memish Ziad A, Ghazal Sameeh, Al Faraj Sarah, Al-Hameed Fahad, AlSaedi Asim, Mandourah Yasser, Al Mekhlafi Ghaleb A, Sherbeeni Nisreen Murad, Elzein Fatehi Elnour, Almotairi Abdullah, Al Bshabshe Ali, Kharaba Ayman, Jose Jesna, Al Harthy Abdulrahman, Al Sulaiman Mohammed, Mady Ahmed, Fowler Robert A, Hayden Frederick G, Al-Dawood Abdulaziz, Abdelzaher Mohamed, Bajhmom Wail and Hussein Mohamed A. 20200916. Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial. : Trials.
Harvard
Arabi Y. M., Asiri A. Y., Assiri A. M., Aziz Jokhdar H. A., Alothman A., Balkhy H. H., AlJohani S., Al Harbi S., Kojan S., Al Jeraisy M., Deeb A. M., Memish Z. A., Ghazal S., Al Faraj S., Al-Hameed F., AlSaedi A., Mandourah Y., Al Mekhlafi G. A., Sherbeeni N. M., Elzein F. E., Almotairi A., Al Bshabshe A., Kharaba A., Jose J., Al Harthy A., Al Sulaiman M., Mady A., Fowler R. A., Hayden F. G., Al-Dawood A., Abdelzaher M., Bajhmom W. and Hussein M. A. (20200916). Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial. : Trials.
MLA
Arabi Yaseen M, Asiri Ayed Y, Assiri Abdullah M, Aziz Jokhdar Hani A, Alothman Adel, Balkhy Hanan H, AlJohani Sameera, Al Harbi Shmeylan, Kojan Suleiman, Al Jeraisy Majed, Deeb Ahmad M, Memish Ziad A, Ghazal Sameeh, Al Faraj Sarah, Al-Hameed Fahad, AlSaedi Asim, Mandourah Yasser, Al Mekhlafi Ghaleb A, Sherbeeni Nisreen Murad, Elzein Fatehi Elnour, Almotairi Abdullah, Al Bshabshe Ali, Kharaba Ayman, Jose Jesna, Al Harthy Abdulrahman, Al Sulaiman Mohammed, Mady Ahmed, Fowler Robert A, Hayden Frederick G, Al-Dawood Abdulaziz, Abdelzaher Mohamed, Bajhmom Wail and Hussein Mohamed A. Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial. : Trials. 20200916.